Second quarter revenue growth up 4%
X-Twist™510(k) clearance received; Limited market release on schedule for 2H 2022
BEDFORD, Mass., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today reported financial results for its second quarter ended June 30, 2022.
Read more at globenewswire.com